Abbott Laboratories Stock News

Lathrop Investment Management Corp lessened its stake in Abbott Laboratories (NYSE:ABT) by 2.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,175 shares of the healthcare product makers stock after selling 100 shares during the period. Lathrop Investment []

Analysts expect Abbott Laboratories (NYSE:ABT) to report $1.16 earnings per share (EPS) for the current fiscal quarter, according to Zacks. Six analysts have issued estimates for Abbott Laboratories earnings, with the highest EPS estimate coming in at $1.20 and the lowest estimate coming in at $1.12. Abbott Laboratories posted earnings of $1.45 per share in []

First Citizens Financial Corp lowered its stake in Abbott Laboratories (NYSE:ABT) by 5.1% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,846 shares of the healthcare product makers stock after selling 100 shares during the quarter. First Citizens Financial Corps holdings in []

Overview Drugs affect individuals in various ways. For example, one drug may cause an increased heart rate, slightly faster breathing and an increase in blood pressure while another may cause drowsiness, lack of focus and memory loss. These differences in the

Investors are optimistic about Abbott (ABT) owing to strong third-quarter results and bullish 2021 outlook.

Home Medical Equipment Market research report covering the current trend and effect on the business of COVID-19. This intelligence report includes investigations based on Current scenarios, Historical records, and future predictions. The thorough research report contains all the vital information

The Hemostasis and Coagulation Analyzer Market Report 2021-2027 provides global market size, regional and national level market size, market segment growth, market share, competitive landscape, sales analysis, influence of domestic and global market participants, and value chain Detailed analysis of

Columbia Trust Co 01012016 lifted its holdings in shares of Abbott Laboratories (NYSE:ABT) by 9.9% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 5,730 shares of the healthcare product makers stock after acquiring an additional 516 shares during the quarter. Columbia Trust Co 01012016s []

Northwest Bancshares Inc. grew its holdings in Abbott Laboratories (NYSE:ABT) by 1.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,758 shares of the healthcare product maker’s stock after purchasing an additional 109 shares during the quarter. Northwest Bancshares Inc.’s holdings […]

Overview: Home healthcare includes services and devices for patients that regularly monitor vital signs such as body temperature, blood pressure pulse rate and chronic health conditions. Rising cases of chronic diseases is expected to boost growth of the global home healthcare

The HbA1c Testing Device Market Report 2021-2027 provides global market size, regional and national level market size, market segment growth, market share, competitive landscape, sales analysis, influence of domestic and global market participants, and value chain Detailed analysis of optimization,

Portland Global Advisors LLC grew its stake in shares of Abbott Laboratories (NYSE:ABT) by 13.9% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 8,108 shares of the healthcare product makers stock after purchasing an additional 987 shares during the period. Portland Global Advisors LLCs holdings in []

Jacobs & Co. CA grew its position in Abbott Laboratories (NYSE:ABT) by 0.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 78,726 shares of the healthcare product makers stock after purchasing an additional 166 shares during the period. Jacobs & Co. CAs []

WestHill Financial Advisors Inc. bought a new stake in Abbott Laboratories (NYSE:ABT) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 2,447 shares of the healthcare product makers stock, valued at approximately $289,000. Several other hedge funds have also bought and sold shares []

The "Organic Baby Food Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Product (Prepared Baby Food, Dried Baby Food, Infant Milk Formula, Others (Biscuits Puffs and Snacks)); Distribution Channel (Supermarket, Hypermarket, Convenience Stores, Online, Other Distribution